Magnitude of cardiac abnormality and its associated factors among hyperthyroidism patients on follow-up at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
Cardiac abnormality
Ethiopia
Hyperthyroidism
Tikur Anbessa Specialized Hospital
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
14 Oct 2024
14 Oct 2024
Historique:
received:
27
05
2023
accepted:
19
09
2024
medline:
15
10
2024
pubmed:
15
10
2024
entrez:
14
10
2024
Statut:
epublish
Résumé
Thyroid hormones have an effect on every organ system, in particular, the heart responds to minimal changes in serum thyroid hormone level. Thyroid hormone causes a lot of changes in the cardiovascular system, such as increased heart rate, contractility, systolic hypertension, changes in peripheral vascular resistance, atrial fibrillation (AF), and hypercoagulability from the direct effect of thyroid hormone on cardiac myocyte and /or due to increased metabolic state. However, the magnitude of such heart abnormalities and its associated factors were not well studied in Ethiopia. To determine the magnitude of cardiac abnormality and its associated factors among hyperthyroidism patients on follow-up at Tikur Anbessa Specialized Hospital (TASH), Addis Ababa, Ethiopia, 2022. An institution-based cross-sectional study was carried out among 318 hyperthyroid patients who were on follow-up at the endocrine clinic of TASH, Addis Ababa, Ethiopia from June to October 2022. The data were collected using a pretested structured interviewer administered questionnaire. The data were entered into the computer using EpiData version 3.1 and analyzed using SPSS version 25 software. Bivariable and multivariable logistic regression models were fitted to determine the association between the independent and dependent variables. Adjusted odds ratio with its 95% confidence interval and p-value < 0.05 were used to declare the presence and strength of statistically significant associations. In this study a total of 318 hyperthyroid patients were participated, most (90.9%) of them were females. The overall prevalence of heart failure among hyperthyroid patients was 17.0% (95% CI = 13.0, 21.6). More than half (52.7%) and one third (33.2%) of the participants showed abnormal electrocardiographic and echocardiographic findings respectively. Marital status (not married) [AOR = 2.37, 95% CI (1.03, 5.44)], pattern of hyperthyroidism [AOR = 13.09, 95% CI (4.70, 36.41)], being Asthmatic [AOR = 7.63, 95% CI (1.55, 37.52)], type of medication [AOR = 3.49, 95% CI (1.11, 11.02)] and duration of treatment [AOR = 4.95, 95% CI (2.05,11.99)] were significantly associated with cardiac abnormality. A significant portion of hyperthyroid patients overburdened by cardiac abnormalities. Being unmarried, overt hyperthyroid, Asthmatic, long stay on treatment and type of treatment were significantly associated with cardiac abnormality. Hence, attention should be given for cardiac abnormalities while treating hyperthyroid patients.
Sections du résumé
BACKGROUND
BACKGROUND
Thyroid hormones have an effect on every organ system, in particular, the heart responds to minimal changes in serum thyroid hormone level. Thyroid hormone causes a lot of changes in the cardiovascular system, such as increased heart rate, contractility, systolic hypertension, changes in peripheral vascular resistance, atrial fibrillation (AF), and hypercoagulability from the direct effect of thyroid hormone on cardiac myocyte and /or due to increased metabolic state. However, the magnitude of such heart abnormalities and its associated factors were not well studied in Ethiopia.
OBJECTIVE
OBJECTIVE
To determine the magnitude of cardiac abnormality and its associated factors among hyperthyroidism patients on follow-up at Tikur Anbessa Specialized Hospital (TASH), Addis Ababa, Ethiopia, 2022.
METHODS
METHODS
An institution-based cross-sectional study was carried out among 318 hyperthyroid patients who were on follow-up at the endocrine clinic of TASH, Addis Ababa, Ethiopia from June to October 2022. The data were collected using a pretested structured interviewer administered questionnaire. The data were entered into the computer using EpiData version 3.1 and analyzed using SPSS version 25 software. Bivariable and multivariable logistic regression models were fitted to determine the association between the independent and dependent variables. Adjusted odds ratio with its 95% confidence interval and p-value < 0.05 were used to declare the presence and strength of statistically significant associations.
RESULT
RESULTS
In this study a total of 318 hyperthyroid patients were participated, most (90.9%) of them were females. The overall prevalence of heart failure among hyperthyroid patients was 17.0% (95% CI = 13.0, 21.6). More than half (52.7%) and one third (33.2%) of the participants showed abnormal electrocardiographic and echocardiographic findings respectively. Marital status (not married) [AOR = 2.37, 95% CI (1.03, 5.44)], pattern of hyperthyroidism [AOR = 13.09, 95% CI (4.70, 36.41)], being Asthmatic [AOR = 7.63, 95% CI (1.55, 37.52)], type of medication [AOR = 3.49, 95% CI (1.11, 11.02)] and duration of treatment [AOR = 4.95, 95% CI (2.05,11.99)] were significantly associated with cardiac abnormality.
CONCLUSION
CONCLUSIONS
A significant portion of hyperthyroid patients overburdened by cardiac abnormalities. Being unmarried, overt hyperthyroid, Asthmatic, long stay on treatment and type of treatment were significantly associated with cardiac abnormality. Hence, attention should be given for cardiac abnormalities while treating hyperthyroid patients.
Identifiants
pubmed: 39402443
doi: 10.1186/s12872-024-04212-3
pii: 10.1186/s12872-024-04212-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
558Informations de copyright
© 2024. The Author(s).
Références
Fadeyev VV. Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Clin Experimental Thyroidol. 2017;13(3):45–56.
doi: 10.14341/ket2017345-56
Albakri A. Thyrotoxic heart failure: a review of clinical status and meta-analysis of electrocardiogram diagnosis and medical clinical management methods. Integr Mol Med. 2018;5:1–11.
Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99(1).
Fadel BM, Ringel MD, Lindsay J, Wartofsky L, Burman HD, Fadel BM. Hyperthyroid Heart Disease. 23.; 2000.
Wyne KL, Nair L, Schneiderman CP, Pinsky B, Antunez Flores O, Guo D, et al. Hypothyroidism Prevalence in the United States: a retrospective study combining National Health and Nutrition Examination Survey and Claims Data, 2009–2019. J Endocr Soc. 2023;7(1):bvac172.
doi: 10.1210/jendso/bvac172
Osman F, Franklyn JA, Holder RL, Sheppard MC, Gammage MD. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy. A matched case-control study. J Am Coll Cardiol. 2007;49(1):71–81. https://doi.org/10.1016/j.jacc.2006.08.042 .
doi: 10.1016/j.jacc.2006.08.042
pubmed: 17207725
Chyou JY, Barkoudah E, Dukes JW, Goldstein LB, Joglar JA, Lee AM, et al. Atrial fibrillation occurring during Acute Hospitalization: A Scientific Statement from the American Heart Association. Circulation. 2023;147(15):e676–98.
doi: 10.1161/CIR.0000000000001133
pubmed: 36912134
Sohn SY, Lee E, Lee MK, Lee JH. The association of overt and subclinical hyperthyroidism with the risk of cardiovascular events and cardiovascular mortality: Meta-analysis and systematic review of cohort studies. Endocrinol Metabolism. 2021;35(4):786–800. https://doi.org/10.3803/ENM.2020.728 .
doi: 10.3803/ENM.2020.728
Kudan S, Lal M, Angral R. The Prevalence of Cardiovascular abnormalities in Thyrotoxicosis A Cross Sectional Study. J Med. 2015;16(2):69–72.
Khurana NK, Kumar S, Kumar S, Kumar P, Rizwan A. Frequency of Cardiovascular Manifestation in patients with hyperthyroidism. Cureus. 2021;13(1):e12839. https://doi.org/10.7759/cureus.12839 . PMID: 33633879; PMCID: PMC7899246.
doi: 10.7759/cureus.12839
pubmed: 33633879
pmcid: 7899246
Shreya DMP. Dr.Akanksha,Dr. Bijoy Jyoti Saikia, Dr.Peddi. Assessment of cardiovascular manifestations of hyperthyroid disorder patients. Eur J Mol Clin Med. 2021;7(11):9414–7.
Reddy V, Taha W, Kundumadam S, Khan M. Atrial fibrillation and hyperthyroidism: a literature review. Indian Heart J. 2017 Jul-Aug;69(4):545–50. https://doi.org/10.1016/j.ihj.2017.07.004 . Epub 2017 Jul 5. PMID: 28822529; PMCID: PMC5560908.
Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clinica E investigacion en arteriosclerosis: publicacion oficial de la Sociedad. Esp De Arterioscler. 2014;26(6):296–309.
Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists. 2002;8(6):457–69.
doi: 10.4158/1934-2403-8.6.457
Mahmood SS, Wang TJ. The epidemiology of congestive heart failure: the Framingham Heart Study perspective. Global Heart. 2013;8(1):77–82.
doi: 10.1016/j.gheart.2012.12.006
pubmed: 23998000
Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the heart. Methodist Debakey Cardiovasc J. 2017;13(2):60–3.
doi: 10.14797/mdcj-13-2-60
pubmed: 28740583
pmcid: 5512680
Frost L, Vestergaard PM, Mosekilde L. Hyperthyroidism and risk of Atrial Fibrillation or Flutter: a Population-based study. Arch Intern Med. 2004;164:1675–8.
doi: 10.1001/archinte.164.15.1675
pubmed: 15302638
Wong C-L, Tam H-KV, Fok C-KV, Lam P-KE, Fung L-M. Thyrotoxic atrial fibrillation: Factors associated with persistence and risk of ischemic stroke. Journal of Thyroid Research. 2017;2017.
Delitala AP. Subclinical hyperthyroidism and the cardiovascular disease. Horm Metab Res. 2017;49(10):723–31.
doi: 10.1055/s-0043-117893
pubmed: 28915531
Biondi B, Kahaly GJ. Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Reviews Endocrinol. 2010;6(8):431–43.
doi: 10.1038/nrendo.2010.105
Mulatu HA. Pattern and presentation of thyro-cardiac disease among patients with hyperthyroidism attending a tertiary hospital in Ethiopia: a cross sectional study. Ethiop J Health Sci. 2019;29(1).
Hussein M, Toraih E, Reisner ASC, Miller P, Corsetti R, Kandil E. Prevalence and mortality of cardiovascular events in patients with hyperthyroidism: a nationwide cohort study in the United States. Gland Surg. 2021;10(9):2608–21. https://doi.org/10.21037/gs-21-236 . PMID: 34733711; PMCID: PMC8514320.
doi: 10.21037/gs-21-236
pubmed: 34733711
pmcid: 8514320
Biondi B. Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur J Endocrinol. 2012;167(5):609 – 18. doi: 10.1530/EJE-12-0627. Epub 2012 Sep 6. PMID: 22956554.
Panagoulis C, Halapas A, Chariatis E, Driva P, Matsakas E. Hyperthyroidism and the heart. Hellenic J Cardiol. 2008;49(3):169–75.
pubmed: 18543646
Raguthu CC, Gajjela H, Kela I, Kakarala CL, Hassan M, Belavadi R, et al. Cardiovascular involvement in Thyrotoxicosis resulting in Heart failure: the risk factors and hemodynamic implications. Cureus. 2022;14(1):e21213.
pubmed: 35186521
pmcid: 8845451
Reddy V, Taha W, Kundumadam S, Khan M. Atrial fibrillation and hyperthyroidism: a literature review. Indian Heart J. 2017;69(4):545–50.
doi: 10.1016/j.ihj.2017.07.004
pubmed: 28822529
pmcid: 5560908